Alopexx: securities offering (amended)
- Form
- S-1/A
- Filed
- Importance
- Routine
- Accession
- 0001839882-25-001330
- Document
- S-1/A
- Exhibit 10.8
- Amendment to collaboration and license agreement
- Exhibit 10.9
- Stock purchase agreement
- Exhibit 10.10
- Employment agreement with daniel r vlock
- Exhibit 10.11
- Employment agreement with thomas t. thomas
- Exhibit 10.12
- Amended and restated consulting agreement
Not explained yet; the original is on EDGAR.
Securities offering (amended)
Similar companies
Same SIC code (2836) and public float not reported.
- Adaptimmune Therapeutics ADAP
- Adverum Biotechnologies ADVM
- AgomAb Therapeutics AGMB
- Alvotech ALVO
- Argenx ARGX